USPTO 2015–2025 USPTO PatentsView US Corporation

Biomet Sports Medicine, LLC

USPTO PatentsView assignee record - 196 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Biomet ranks #2,029 of 49,997 tracked US assignees by granted-patent volume, with 196 patents across 7 technology areas.

#2,029
of 49,997 US assignees by volume
Top 29%
by Innovation Score (42.9/100)
19.9
avg claims per patent
-42%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2029 · US Corporation #2,029 · 196 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 196 grants
  • TOP-DECILE #2,029/49,997
  • PHOTO-FINISH Nektar Therapeutics
  • CPC-NARROW A61B · 7 areas
  • INNOV-PAR 42.9/100
  • CLAIMS-RICH 19.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -42% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nektar Therapeutics (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomet’s 42.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Biomet

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biomet's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Biomet?

Each dot is one of Biomet’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomet’s own 19.9 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biomet vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 195.5196196.5197197.5 0510152025 Granted patents (volume) Avg claims / patent PsiQuantum Corp. - 197, 18.03PsiquantumSorin CRM SAS - 197, 17.22Sorin CRM SASSecurus Technologies, LLC - 197, 20.96SecurusTimotion Technology Co., Ltd. - 197, 5.15Timotion Technolo…Nektar Therapeutics - 196, 12.49Nektar Therapeuti…Olympus Winter & IBE GMBH - 196, 11.64Olympus Winter &…Specialized Bicycle Components, Inc. - 196, 13.29Specialized Bicyc…True Velocity IP Holdings, Inc. - 196, 12.32True Velocity IP…Biomet Sports Medicine, LLC - 196, 19.89Biomet Sports Med…
Biomet vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomet's grants concentrate

Biomet Sports Medicine, LLC is a focused PatentsView assignee: 7 CPC subclasses with 99% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (31 grants) versus a trough of 6 in 2024. By volume, Biomet sits between PsiQuantum Corp. and True Velocity IP Holdings, Inc..

Biomet's three-year grant acceleration

From 2019–2021 to 2022–2024, Biomet Sports Medicine, LLC moved from 57 to 29 grants (0.51x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,673. See the growth leaderboard.

Who files at Biomet's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biomet holds 196 patents at rank #2,029, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biomet

By rank, the assignees closest to #2,029 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Biomet's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biomet, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Biomet ranks #101 of 7,127 assignees by patent count in that subclass.

Biomet's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biomet Sports Medicine, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 21 10.7%
2016 31 15.8%
2017 27 13.8%
2018 21 10.7%
2019 18 9.2%
2020 24 12.2%
2021 15 7.7%
2022 13 6.6%
2023 10 5.1%
2024 6 3.1%
2025partial year 10 5.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Biomet Sports Medicine, LLC's patent record in context - here's where to go next.

  • Biomet Sports Medicine, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 99% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #2,029 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biomet Sports Medicine, LLC against PsiQuantum Corp., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.